Matthew G.Latham (Matt)

Partner

悉尼 + 61.2.8272.0500

聯絡

*Share

Matt Latham's practice focuses on mergers and acquisitions and private equity transactions. He has represented Australian and offshore acquirers and targets in a number of acquisitions, divestitures, take-private transactions, buyouts, and joint ventures. He also advises clients on various corporate-related matters, including directors' duties, corporate governance, and disclosure.

Matt has recently advised Australian Health Management in its A$367 million demutualisation and sale to Medibank Private; a consortium consisting of HarbourVest Partners, Paul Capital Partners, Pantheon Ventures, and Partners Group in its A$837 million take private of Macquarie Capital Group Alliance; and Bear Stearns Private Equity in its A$115 take private of Macquarie Private Capital Group.

Matt has published a number of articles and is a frequent speaker on mergers and acquisitions, private equity, and directors' duties.

執業經驗

  • rt health and HCF announce merger agreementJones Day advised Railway & Transport Health Fund Ltd (rt health) in its merger with Australia’s third largest private health insurer, the Hospitals Contribution Fund of Australia Limited (HCF).
  • FuseFX acquires Rising Sun PicturesJones Day advised FuseFX, a portfolio company of EagleTree Capital, in connection with the acquisition and financing of Rising Sun Pictures, a world-renowned, high-end visual effects studio headquartered in Adelaide, Australia.
  • Horizon Global sells Asia-Pacific Business segment to Pacific Equity Partners for AU$340 million (US$233 million)Jones Day advised Horizon Global Corporation (NYSE: HZN), one of the world's leading manufacturers of branded towing, trailering, cargo management, and related accessories, on the AU$340 million (US$233 million) sale of its Australian and Asia-Pacific division to Pacific Equity Partners.
  • NEP Group acquires Broadcast Sports International, LLCJones Day advised NEP Group in its acquisition of Broadcast Sports International, LLC, a leading provider of radio-frequency audio-visual solutions to the live sports and broadcast television industry.
  • NEP acquires Big Picture in Australia and New ZealandJones Day advised NEP Group in its acquisition of Big Picture in Australia and New Zealand, a leading supplier of video production and equipment for concert tours, music festivals, broadcast, corporate and special events.
  • Riverside sells MNX Global Logistics to Audax Private EquityJones Day advised The Riverside Company in connection with its sale of MNX Global Logistics, a leading provider of time-critical logistics services for sensitive, high value goods, to Audax Private Equity.
  • MedHealth Group acquires Work Health GroupJones Day advised MedHealth Group, Australia's leading provider of independent, evidence-based medical advisory services, in its acquisition of the Work Health Group, which comprises five businesses that provide employment services, advisory services, and workplace rehabilitation.
  • EagleTree Capital portfolio company acquires HotelsWorldJones Day represented EagleTree Capital in connection with the acquisition by portfolio company Northstar Travel Group, a leading provider of business-to-business information, content, events, data, research, custom content, and software dedicated to the global travel and meeting industries, of HotelsWorld, a suite of industry events for senior hotel executives in the Australia and New Zealand region.
  • Riverside acquires Logical Freight SolutionsJones Day represented The Riverside Company in connection with the add-on acquisition and related financing to the MNX Global Logistics (MNX) platform of Logical Freight Solutions P/L, an Australian-based logistics provider for the healthcare, life sciences, and biotech markets with operations based in Australia, and extending to New Zealand, Taiwan, Hong Kong, Singapore and the U.S.
  • Plarium acquires Rumble EntertainmentJones Day advised Plarium LLC in its acquisition of Rumble Entertainment (also known as Rumble Games), a studio that focuses on fantasy role-playing games.
  • Jennmar enters into acquisitions and divestitures agreement with DYWIDAG Systems InternationalJones Day advised Jennmar in its agreements to conduct a series of international acquisitions and divestitures with DYWIDAG Systems International ("DSI").
  • Riverside acquires Global Orthopaedic TechnologiesJones Day advised The Riverside Company in connection with its acquisition of Global Orthopaedic Technologies, an Australian manufacturer and distributor of orthopaedic implants.
  • Sinclair Knight Merz completes AU$1.3 billion (US$1.2 billion) merger with Jacobs Engineering GroupJones Day advised Sinclair Knight Merz ("SKM") in the AU$1.3 billion (US$1.2 billion) all cash merger with Jacobs Engineering Group Inc. ("Jacobs") via two separate but inter-conditional Schemes of Arrangement.
  • Riverside portfolio company acquires Cibo EspressoJones Day advised The Riverside Company in connection with its acquisition and related financing by portfolio company Retail Zoo of Cibo Espresso, an Australian franchisor of premium espresso bars.
  • Riverside acquires Learning SeatJones Day advised The Riverside Company in connection with its acquisition and related financing of Learning Seat, a Melbourne, Australia-based developer and provider of eLearning courses.
  • Jones Day's Sydney office hosts boardroom lunch for John Wood, founder and Board Chair of Room to ReadMatt Latham, and other partners and lawyers of the Firm's Sydney office, hosted a private boardroom lunch for John Wood, the Founder and Board Chair of Room to Read in March 2011.
  • Weir Group acquires Linatex Consolidated HoldingsJones Day advised The Weir Group PLC, a British engineering company headquartered in Glasgow, Scotland, in connection with its $200 million acquisition of Linatex Consolidated Holdings Limited, a global provider of wear-resistant products to the mining industry, from Navis Capital.
  • Procter & Gamble acquired Ambi Pur, the air care business of Sara Lee, for $470 millionJones Day advised The Procter & Gamble Co. ("P&G") in its purchase of Sara Lee's Ambi Pur Business for EU 320 million ($470 million).
  • Riverside acquires Australian Medico Legal ServicesJones Day advised The Riverside Company in connection with its acquisition of the assets and business of Australian Medico Legal Services (MLCOA), a provider of independent medical assessments and related medical advisory services for insurance organizations, corporations, government, and legal entities.
  • Riverside acquires Boost Investment GroupJones Day advised The Riverside Company in connection with its acquisition of a majority stake in Boost Investment Group, the owners of Boost Juice Bars and Salsa's Fresh Mex Grill.
    •

    July 2024 Commentary

    The Regulation of Foreign Direct Investment in Australia: Australian Treasury's Recent Facts and Figures

    May 2024 Commentary

    Australian Government Announces Procedural Reforms to Strengthen and Streamline Australia's Foreign Investment Policy

    May 2024 Commentary

    Changes to Disclosure in Annual Reports: New Australian Requirements to Report on Subsidiaries

    APRIL 2024 Commentary

    Substantial Strengthening of Australia's Foreign Bribery Laws: Are Your Procedures up to Scratch?

    FEBRUARY 2024 Commentary

    United States Leads the Way With Recent Foreign Investment Into Australia

    June 2023 Commentary

    Australia's New Register of Foreign Ownership of Australian Assets Commences on July 1, 2023

    July 2022 Commentary

    Australia Foreign Investment Fees Set to Double

    March 2022 Newsletters

    Vital Signs: Digital Health Law Update | Winter 2022

    February 2022 Commentary

    The Australian Parliament Enacts Magnitsky-style Laws

    August 2021 Newsletters

    Vital Signs: Digital Health Law Update | Summer 2021
    顯示全部

    • February 23, 2010
      2010 Speaker Series: Asia-Pacific, the Middle East, and Europe

    *Before sending, please note:

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.